{"id":11139,"date":"2025-07-27T09:56:47","date_gmt":"2025-07-27T07:56:47","guid":{"rendered":"https:\/\/valintermed.com\/?p=11139"},"modified":"2025-07-27T09:56:47","modified_gmt":"2025-07-27T07:56:47","slug":"epitelialno-mioepitelialnaya-kartsinoma","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/epitelialno-mioepitelialnaya-kartsinoma\/","title":{"rendered":"Epithelial-myoepithelial carcinoma"},"content":{"rendered":"
<\/div>\n

Epithelial-myoepithelial carcinoma (EMC) is a rare but aggressive tumor type that arises from epithelial and myoepithelial tissue. This disease mainly affects the salivary glands, but other localizations are also possible, such as the mammary glands and lungs. EMC is characterized by the presence of atypical cells that have a high potential for invasion and metastasis. This disease is most often observed in middle-aged women, but it can also be diagnosed in men and at a younger age. The tumor can manifest as a painless formation, which complicates early diagnosis and adequate therapy. The need for EMC examination is due to both clinical and pathomorphological aspects, which require more detailed study.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n